Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

DR REDDYS LABORATORIES LTD (RDY) Form 6-K — Sep 22, 2026

$RDYForm 6-KFiled Sep 22, 2026, 2:19 PM ET0001575872-26-000661Original filing

Dr. Reddy's Laboratories announced that its Board of Directors will meet on Friday, October 23, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ending September 30, 2026. Under SEBI insider trading regulations, the trading window for dealing in the company's securities will be closed from September 24, 2026 to October 25, 2026, both days inclusive. The filing is purely procedural and gives no indication of the content of the upcoming results, but it confirms the timing of Dr.

Key figures

Quarter end
September 30, 2026
Board meeting date
October 23, 2026
Trading window closure
September 24, 2026 to October 25, 2026

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.